Aprepitant, a Neurokinin-1 Receptor Antagonist, for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Randomized, Double-blind, Placebo Controlled Trial

2011 ◽  
Vol 106 ◽  
pp. S54
Author(s):  
Tilak Shah ◽  
Martin Poleski ◽  
Stanley Branch ◽  
Paul Jowell ◽  
Jorge Obando ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document